SIREN : 817553449
MEDIFIELD is a French company founded 10 years ago, specialized in the sector Conseil pour les affaires et autres conseils de gestion. Based in NEUILLY-SUR-SEINE (92200), this company of category PME shows in 2024 a revenue of 1.6 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-04-25
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 558 605 € | 2 570 544 € | 3 960 183 € | 3 779 889 € | 3 133 273 € | 3 238 892 € | 2 842 935 € | 1 514 560 € | 1 256 480 € |
| Net income | 1 664 € | 4 798 € | -1 599 € | -4 988 € | -609 € | 3 165 € | 27 360 € | 11 736 € | 28 765 € |
| EBITDA | -10 626 € | -28 940 € | -60 033 € | -55 297 € | -50 685 € | -35 770 € | -13 234 € | -6 748 € | 6 727 € |
| Net margin | 0.1% | 0.2% | -0.0% | -0.1% | -0.0% | 0.1% | 1.0% | 0.8% | 2.3% |
In 2024, MEDIFIELD achieves revenue of 1.6 M€. Revenue is growing positively over 9 years (CAGR: +2.7%). Significant drop of -39% vs 2023. After deducting consumption (5 €), gross margin stands at 1.6 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -11 k€, representing -0.7% of revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 2 k€, i.e. 0.1% of revenue. This profit can be retained or distributed to shareholders.
1 558 605 €
1 558 600 €
-10 626 €
1 796 €
1 664 €
-0.7%
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 28%. The balance between equity and debt is satisfactory.
0.0%
28.334%
-0.733%
0.0
In 2024, the debt ratio of MEDIFIELD (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2024, the financial autonomy of MEDIFIELD (28.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of MEDIFIELD (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 139.54. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
139.536
0.0
In 2024, the liquidity ratio of MEDIFIELD (139.54) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2024, the interest coverage of MEDIFIELD (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 30 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 12 days. The company must finance 18 days of gap between collections and payments. WCR is negative (-0 days): operations structurally generate cash. Over 2016-2024, WCR increased by +97%, requiring additional financing.
-670 €
30 j
12 j
0 j
0 j
Based on 69 transactions of similar company sales
in 2024,
the value of MEDIFIELD is estimated at
620 788 €
(range 360 338€ - 692 884€).
The price/revenue ratio is 0.66x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 69 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare MEDIFIELD with other companies in the same sector:
Voir toutes les statistiques du secteur Conseil pour les affaires et autres conseils de gestion
The revenue of MEDIFIELD in 2024 is 1.6 M€.
Yes, MEDIFIELD generated a net profit of 2 k€ in 2024.
The headquarters of MEDIFIELD is located in NEUILLY-SUR-SEINE (92200), in the department Hauts-de-Seine.
The tax return of MEDIFIELD is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
MEDIFIELD operates in the sector Conseil pour les affaires et autres conseils de gestion (NAF code 70.22Z). See the 'Sector positioning' section above to compare the company with its competitors.